Clinical trial
An Exploratory Clinical Study Evaluating the Safety and Efficacy of Infusing the Non-virally Prepared BCMA/CD19 Bispecific CAR-T Cell Injection in Patients With Partially Relapsed/Refractory Autoimmune Diseases.
NCT07604792 is registered in ClinicalTrials.gov with Beijing Boren Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Exploratory Clinical Study Evaluating the Safety and Efficacy of Infusing the Non-virally Prepared BCMA/CD19 Bispecific CAR-T Cell Injection in Patients With Partially Relapsed/Refractory Autoimmune Diseases.
- Lead sponsor
- Beijing Boren Hospital
- Phase
- Phase 1
- Overall status
- Suspended
- Start date
- September 25, 2025
- Completion date
- November 30, 2041
- Enrollment
- 9 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.